Search News:

By Year : Latest  |  All  |   2024  |  2023  |  2022  |  2021  |  2020  |  2019  |  2018  |  2017


Reporting Disposition of Share Repurchase for Financial Management Purposes as of 21 December 2021
Reporting Disposition of Share Repurchase for Financial Management Purposes as of 20 December 2021
The establishment of a new subsidiary (revised 2)
The establishment of a new subsidiary (revised)
The establishment of a new subsidiary
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2021
Financial Performance Quarter 3 (F45) (Reviewed)
Financial Statement Quarter 3/2021 (Reviewed)
Invitation to Shareholders to Propose Agenda, Director Nominees and any inquiries in advance of Shareholders' 2022 Annual General Meeting
Entry into the related party transaction
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2021
Financial Performance Quarter 2 (F45) (Reviewed)
Financial Statement Quarter 2/2021 (Reviewed)
Notification on major shareholder not having other interests that may conflict with the interests of the Company's businesses
Notification of a change of corporate secretary
Notification appointment of replacement executives
Clarification of vaccine import as requested by the SEC Office
Clarification of COVID-19 vaccine procurement, mRNA technology (Addition)
SET advices investors to make investment decision carefully on THG's securities.
Clarification of COVID-19 vaccine procurement, mRNA technology
<<< <
/ 2
>>>